These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22043058)

  • 21. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
    ; Tanner M; Isola J; Wiklund T; Erikstein B; Kellokumpu-Lehtinen P; Malmström P; Wilking N; Nilsson J; Bergh J
    J Clin Oncol; 2006 Jun; 24(16):2428-36. PubMed ID: 16682728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy: updates and new perspectives.
    Swain SM
    Oncologist; 2010; 15 Suppl 5():8-17. PubMed ID: 21138951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of individual patients is more than a trial.
    Bottini A; Berruti A; Generali D; Dogliotti L
    J Natl Cancer Inst Monogr; 2011; 2011(43):53-4. PubMed ID: 22043040
    [No Abstract]   [Full Text] [Related]  

  • 25. Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.
    Masuda H; Masuda N; Kodama Y; Ogawa M; Karita M; Yamamura J; Tsukuda K; Doihara H; Miyoshi S; Mano M; Nakamori S; Tsujinaka T
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):911-7. PubMed ID: 20593180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
    Bertucci F; Borie N; Roche H; Bachelot T; Le Doussal JM; Macgrogan G; Debono S; Martinec A; Treilleux I; Finetti P; Esterni B; Extra JM; Geneve J; Hermitte F; Chabannon C; Jacquemier J; Martin AL; Longy M; Maraninchi D; Fert V; Birnbaum D; Viens P
    Breast Cancer Res Treat; 2011 Jun; 127(2):363-73. PubMed ID: 20585850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant therapy as a platform for drug development and approval in breast cancer.
    Bardia A; Baselga J
    Clin Cancer Res; 2013 Dec; 19(23):6360-70. PubMed ID: 24298066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity.
    Bozzetti C; Musolino A; Camisa R; Bisagni G; Flora M; Bassano C; Martella E; Lagrasta C; Nizzoli R; Personeni N; Leonardi F; Cocconi G; Ardizzoni A
    Am J Clin Oncol; 2006 Apr; 29(2):171-7. PubMed ID: 16601438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy: updates and new perspectives.
    Swain SM
    Oncologist; 2011; 16 Suppl 1():30-9. PubMed ID: 21278439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer gene microarrays pass muster.
    Twombly R
    J Natl Cancer Inst; 2006 Oct; 98(20):1438-40. PubMed ID: 17047189
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictive markers of response to neoadjuvant chemotherapy in breast cancer.
    Tewari M; Krishnamurthy A; Shukla HS
    Surg Oncol; 2008 Dec; 17(4):301-11. PubMed ID: 18467090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
    Rodriguez AA; Makris A; Wu MF; Rimawi M; Froehlich A; Dave B; Hilsenbeck SG; Chamness GC; Lewis MT; Dobrolecki LE; Jain D; Sahoo S; Osborne CK; Chang JC
    Breast Cancer Res Treat; 2010 Aug; 123(1):189-96. PubMed ID: 20582464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer.
    Pusztai L; Gianni L
    Nat Clin Pract Oncol; 2004 Nov; 1(1):44-50. PubMed ID: 16264799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
    Straver ME; Glas AM; Hannemann J; Wesseling J; van de Vijver MJ; Rutgers EJ; Vrancken Peeters MJ; van Tinteren H; Van't Veer LJ; Rodenhuis S
    Breast Cancer Res Treat; 2010 Feb; 119(3):551-8. PubMed ID: 19214742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating molecular profiling, histological type and other variables: defining the fingerprint of responsiveness to treatment.
    Viale G
    Breast; 2009 Oct; 18 Suppl 3():S32-6. PubMed ID: 19914539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of the 21-gene assay and its application in clinical practice and clinical trials.
    Sparano JA; Paik S
    J Clin Oncol; 2008 Feb; 26(5):721-8. PubMed ID: 18258979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?
    Di Leo A; Biganzoli L; Claudino W; Licitra S; Pestrin M; Larsimont D
    Eur J Cancer; 2008 Dec; 44(18):2791-8. PubMed ID: 18993056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of chemotherapy-induced tumor gene expression in human breast cancers.
    Tan SH; Lee SC
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):283-306. PubMed ID: 20163320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survivin as a predictive biomarker of complete pathologic response to neoadjuvant chemotherapy in patients with stage II and stage III breast cancer.
    Petrarca CR; Brunetto AT; Duval V; Brondani A; Carvalho GP; Garicochea B
    Clin Breast Cancer; 2011 Apr; 11(2):129-34. PubMed ID: 21569999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to translate preclinical information to breast cancer patient benefit.
    Daidone MG; Zaffaroni N; Cappelletti V
    J Natl Cancer Inst Monogr; 2011; 2011(43):55-9. PubMed ID: 22043041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.